R & D Advantage
  • Close collaboration with and strong technical support from 3 renowned tech-platforms with innovative R&D capacity, including the State Key Laboratory of Pharmaceuticla Biotechnology (SKLPB), Antibody and Immunoassay Services (AIS) of The University of Hong Kong and the Shenzhen Institute of Research and Innovation (SIRI);
  • Strong tract record in biomedical technology and diagnostic assay development;
  • Worldwide network of clinical resources for comprehensive and solid clincal validation and multi-center validation for in-house products;
  • Successful markerting and commercialization of mutiple IVD products worldwide with high recognition from the market.